BioCentury
ARTICLE | Company News

Aeterna Zentaris, Frontier Scientific Inc. deal

December 10, 2007 8:00 AM UTC

AEZ sold its reagent business subsidiary, Echelon Biosciences Inc., to chemistry services company Frontier for $3.2 million. In October, AEZ announced its plans to divest non-core assets to focus on e...